{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:35:41Z","timestamp":1790832941457,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,17]],"date-time":"2021-04-17T00:00:00Z","timestamp":1618617600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pediatr-neonatol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pediatrics &amp; Neonatology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.pedneo.2021.03.018","type":"journal-article","created":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T08:21:13Z","timestamp":1619511673000},"page":"400-405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["A retrospective study of clinical features and outcome in patients with refractory or recurrent hepatoblastoma: A single institution experience"],"prefix":"10.1016","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0716-0838","authenticated-orcid":false,"given":"Jen-Yin","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Chi","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9336-3147","authenticated-orcid":false,"given":"Ting-Huan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Cherng","family":"Sheu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsi-Che","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pedneo.2021.03.018_bib1","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1053\/jhep.2003.50375","article-title":"Epidemiology of primary hepatic malignancies in U.S. children","volume":"38","author":"Darbari","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.pedneo.2021.03.018_bib2","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/00043426-199709000-00002","article-title":"Hepatoblastoma in children: a review","volume":"19","author":"Raney","year":"1997","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.pedneo.2021.03.018_bib3","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/MPH.0b013e3181b6db88","article-title":"Long-term treatment results of hepatoblastoma at a single institution in Taiwan","volume":"31","author":"Hou","year":"2009","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.pedneo.2021.03.018_bib4","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1016\/j.ejca.2012.06.023","article-title":"Efficacy of irinotecan single drug treatment in children with refractory or recurrent hepatoblastoma - a phase II trial of the childhood liver tumour strategy group (SIOPEL)","volume":"48","author":"Zs\u00edros","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.pedneo.2021.03.018_bib5","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/pbc.24218","article-title":"Relapsed hepatoblastoma","volume":"59","author":"Trobaugh-Lotrario","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.pedneo.2021.03.018_bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/MOP.0000000000000046","article-title":"Hepatoblastoma state of the art: pathology, genetics, risk stratification, and chemotherapy","volume":"26","author":"Czauderna","year":"2014","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.pedneo.2021.03.018_bib7","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejca.2015.09.023","article-title":"The Children's Hepatic tumors International Collaboration (CHIC): novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model","volume":"52","author":"Czauderna","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.pedneo.2021.03.018_bib8","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S1470-2045(16)30598-8","article-title":"Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration","volume":"18","author":"Meyers","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.pedneo.2021.03.018_bib9","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s00247-018-4078-z","article-title":"2017 PRETEXT: radiologic staging system for primary hepatic malignancies of childhood revised for the Paediatric Hepatic International Tumour Trial (PHITT)","volume":"48","author":"Towbin","year":"2018","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.pedneo.2021.03.018_bib10","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1002\/cncr.30591","article-title":"Upfront window vincristine\/irinotecan treatment of high-risk hepatoblastoma: a report from the Children's Oncology Group AHEP0731 study committee","volume":"123","author":"Katzenstein","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.pedneo.2021.03.018_bib11","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/pbc.24171","article-title":"Sorafenib and bevacizumab for recurrent metastatic hepatoblastoma: stable radiographic disease with decreased AFP","volume":"59","author":"Marsh","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.pedneo.2021.03.018_bib12","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1158\/1078-0432.CCR-18-2675","article-title":"A phase II study of Alisertib in children with recurrent\/refractory solid tumors or leukemia: children's Oncology Group Phase I and Pilot Consortium (ADVL0921)","volume":"25","author":"Moss\u00e9","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pedneo.2021.03.018_bib13","doi-asserted-by":"crossref","first-page":"e1377872","DOI":"10.1080\/2162402X.2017.1377872","article-title":"Phase I study of glypican-3-derived peptide vaccine therapy for patients with refractory pediatric solid tumors","volume":"7","author":"Tsuchiya","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.pedneo.2021.03.018_bib14","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1200\/JCO.2012.47.0914","article-title":"Phase I pharmacokinetic and pharmacodynamic study of pazopanib in children with soft tissue sarcoma and other refractory solid tumors: a children's oncology group phase I consortium report","volume":"31","author":"Glade Bender","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.pedneo.2021.03.018_bib15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00247-006-0361-5","article-title":"2005 PRETEXT: a revised staging system for primary malignant liver tumours of childhood developed by the SIOPEL group","volume":"37","author":"Roebuck","year":"2007","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.pedneo.2021.03.018_bib16","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1200\/JCO.2000.18.14.2665","article-title":"Randomized comparison of cisplatin\/vincristine\/fluorouracil and cisplatin\/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: a report from the children's cancer group and the pediatric oncology group","volume":"18","author":"Ortega","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.pedneo.2021.03.018_bib17","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1200\/JCO.1991.9.12.2167","article-title":"Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin chemotherapy: a report from the Childrens Cancer Study Group","volume":"9","author":"Ortega","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.pedneo.2021.03.018_bib18","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.pedneo.2021.03.018_bib19","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/mpo.2950190415","article-title":"Cisplatin ototoxicity in children: a practical grading system","volume":"19","author":"Brock","year":"1991","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.pedneo.2021.03.018_bib20","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0022-3468(98)90221-4","article-title":"Successful right trisegmentectomy for ruptured hepatoblastoma with preoperative transcatheter arterial embolization","volume":"33","author":"Chan","year":"1998","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.pedneo.2021.03.018_bib21","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1055\/a-1014-3250","article-title":"High dose chemotherapy with autologous stem cell transplantation in hepatoblastoma does not improve outcome. Results of the GPOH study HB99","volume":"231","author":"H\u00e4berle","year":"2019","journal-title":"Klin Padiatr"},{"key":"10.1016\/j.pedneo.2021.03.018_bib22","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/MPH.0000000000000554","article-title":"Cerebral metastasis of hepatoblastoma: a review","volume":"38","author":"Rai","year":"2016","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.pedneo.2021.03.018_bib23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/MOP.0000000000000042","article-title":"Hepatoblastoma state of the art: pre-treatment extent of disease, surgical resection guidelines and the role of liver transplantation","volume":"26","author":"Meyers","year":"2014","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.pedneo.2021.03.018_bib24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00270-018-2097-7","article-title":"Reiterative radiofrequency ablation in the management of pediatric patients with hepatoblastoma metastases to the lung, liver, or bone","volume":"42","author":"Yevich","year":"2019","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.pedneo.2021.03.018_bib25","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1002\/1097-0142(19950615)75:12<2966::AID-CNCR2820751226>3.0.CO;2-W","article-title":"Etoposide, ifosfamide, and cisplatin therapy for refractory childhood solid tumors. Response and toxicity","volume":"75","author":"van Hoff","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.pedneo.2021.03.018_bib26","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00043426-200202000-00006","article-title":"Phase I trial of cisplatin and topotecan in children with recurrent solid tumors: children's cancer group study 0942","volume":"24","author":"Wells","year":"2002","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.pedneo.2021.03.018_bib27","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/pbc.22544","article-title":"A phase II trial and pharmacokinetic study of oxaliplatin in children with refractory solid tumors: a Children's Oncology Group study","volume":"55","author":"Beaty","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.pedneo.2021.03.018_bib28","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3389\/fped.2016.00022","article-title":"Hepatoblastoma: a need for cell lines and tissue banks to develop targeted drug therapies","volume":"4","author":"Rikhi","year":"2016","journal-title":"Front Pediatr"},{"key":"10.1016\/j.pedneo.2021.03.018_bib29","first-page":"1853","article-title":"Targeting excessive MYCN expression using MLN8237 and JQ1 impairs the growth of hepatoblastoma cells","volume":"54","author":"Eberherr","year":"2019","journal-title":"Int J Oncol"},{"key":"10.1016\/j.pedneo.2021.03.018_bib30","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/pbc.24605","article-title":"Phase 2 trial of cixutumumab in children, adolescents, and young adults with refractory solid tumors: a report from the Children's Oncology Group","volume":"61","author":"Weigel","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.pedneo.2021.03.018_bib31","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jpedsurg.2004.01.035","article-title":"Association between surgical margins and long-term outcome in advanced hepatoblastoma","volume":"39","author":"Dicken","year":"2004","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.pedneo.2021.03.018_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26820","article-title":"Extreme hepatic resections for the treatment of advanced hepatoblastoma: are planned close margins an acceptable approach?","volume":"65","author":"Fonseca","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.pedneo.2021.03.018_bib33","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ejca.2018.10.013","article-title":"Microscopically positive resection margin after hepatoblastoma resection: what is the impact on prognosis? A Childhood Liver Tumours Strategy Group (SIOPEL) report","volume":"106","author":"Aronson","year":"2019","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.pedneo.2021.03.018_bib34","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1200\/JCO.1988.6.4.679","article-title":"A prospective randomized phase III trial comparing combination chemotherapy with cyclophosphamide, fluorouracil, and either doxorubicin or epirubicin. French Epirubicin Study Group","volume":"6","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.pedneo.2021.03.018_bib35","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1200\/JCO.2011.39.1110","article-title":"Platinum-induced ototoxicity in children: a consensus review on mechanisms, predisposition, and protection, including a new International Society of Pediatric Oncology Boston ototoxicity scale","volume":"30","author":"Brock","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.pedneo.2021.03.018_bib36","doi-asserted-by":"crossref","first-page":"5828","DOI":"10.1002\/cncr.24667","article-title":"Amifostine does not prevent platinum-induced hearing loss associated with the treatment of children with hepatoblastoma: a report of the intergroup hepatoblastoma study P9645 as a part of the Children's Oncology Group","volume":"115","author":"Katzenstein","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.pedneo.2021.03.018_bib37","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1056\/NEJMoa1801109","article-title":"Sodium thiosulfate for protection from cisplatin-induced hearing loss","volume":"378","author":"Brock","year":"2018","journal-title":"N Engl J Med"}],"container-title":["Pediatrics &amp; Neonatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875957221000619?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875957221000619?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:56:02Z","timestamp":1761749762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875957221000619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S1875957221000619"],"URL":"https:\/\/doi.org\/10.1016\/j.pedneo.2021.03.018","relation":{},"ISSN":["1875-9572"],"issn-type":[{"value":"1875-9572","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A retrospective study of clinical features and outcome in patients with refractory or recurrent hepatoblastoma: A single institution experience","name":"articletitle","label":"Article Title"},{"value":"Pediatrics & Neonatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pedneo.2021.03.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Taiwan Pediatric Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}